(Total Views: 349)
Posted On: 07/21/2021 11:26:00 AM
Post# of 114

$SRNE News Article - Sorrento Announces Dosing of COVID-19 Patients in Phase 2 Clinical Trial for COVIDROPS, a Highly Potent Neutralizing Antibody Against SARS-CoV-2 Including Delta and Alpha Variants of Concern, in an At-Home Outpatient Setting in United Kingdom https://marketwirenews.com/news-releases/sorr...13650.html


My Twitter: WhyteStocks